Women with breast cancer eventually may be spared from having to undergo toxic treatments thanks to new research that shows levels of ferroportin—a protein that regulates iron in cells—may predict whether the cancer will be aggressive or recurring. … Back to Article
Join AARP
Get exclusive member benefits & effect social change. Join Today
















Tell Us WhatYou Think
Please leave your comment below.
You must be signed in to comment.
Sign In | Register